China Sky One Granted One Approval, Two Drug Trial OKs
publication date: Mar 3, 2009
China Sky One Medical (中国天字一号医药公司) was granted production approval from the SFDA to market calcium folinate injection, an auxiliary therapy for sprue (a disease of the small intestine) and other disorders of the digestive system. At the same time, the company said the SFDA granted approval to begin clinical trials of two TCMs for skin disorders: Paeonol gel and Mei Lu gel. All three products are prescription drugs. More details...
Stock Symbol: (NSDQ: CSKI)
Sorry... this feature or article is only available to subscribers.